General description
Bleomycin is an antineoplastic agent that inhibits DNA metabolism and is used in the treatment of lymphomas and solid tumours.
INN
Bleomycin
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1979
(TRS
641)
for
Hodgkin lymphoma
Added in 1979
(TRS
641)
for
Germ cell tumour of testis
Added in 1979
(TRS
641)
for
Other specified malignant neoplasms of the ovary
Added in 1979
(TRS
641)
for
Kaposi sarcoma of unspecified primary site
Added in 1979
(TRS
641)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Removed in 2015
(TRS
994)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate)
- Parenteral > General injections > unspecified: 15 mg in vial (as sulfate)